SPAIN | ACTIS
06/11/2019
Lmite 23 Sep 2022
Oferta Tecnolgica
Ref.
TOTW20210910001
A Taiwanese Research Institute Is Seeking Collaboration for Developing Anti-Globo H ADC, an Oncology Product, Either Through Licensing, Contract Services or Co-development
A Taiwanese non-profit biomedical research institute is developing Anti-Globo H ADC for cancer treatment. The product is currently in the stage of pre-clinical. They are seeking partners for out-licensing, contract services, and co-development in related to the development of anti-Globo H ADC.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019